Biopharma Marketing-Spend Outlook for 2016 sponsored by Guidemark Health
Date: Thursday, April 21
Time:1:00 PM EST / 10:00 AM PST
Please join us for a webcast discussing key takeaways from the MM&M/Guidemark Health Healthcare Marketers Trend Report. There will be a presentation on the survey results, providing insight into how marketing spend is changing across advertisers and media, along with a deeper dive on some of the specific survey results that may help biopharma brands navigate the marketing landscape in 2016.
Matt Brown, CEO, Guidemark Health
As CEO of Guidemark Health, Matt is responsible for strategic direction and oversight of the agency.
Before joining Guidemark Health, Matt served as general manager of ICC Lowe. In addition to guiding the organizations' transformation, Matt oversaw client relationships, new business activities, and worked closely with clients on the marketing of their products.
Prior to ICC Lowe, Matt served as president of Ignite Health. During his tenure the agency was nominated for Agency of the Year in recognition of significant growth and expansion. Matt expanded the agency's offerings through the acquisition of key companies and recruitment of great talent.
Matt served as senior vice president/managing director for GSW Worldwide prior to joining Ignite Health. During his 10 years at GSW, he held a number of positions with responsibility for leading account services, new business, staff development, as well as innovative business models and communications solutions for clients.
Matt is a graduate of The Ohio State University and served in the Army National Guard for 6 years before starting his professional career. Matt lives in Long Valley, New Jersey, with his wife and 3 children.
Fred Petito , Chief Behavioral and Engagement Officer, Guidemark Health
Fred is a seasoned digital and multichannel marketer with nearly 20 years' experience planning and implementing communications programs for clients in a range of industries and at leading agencies such as Ogilvy, Grey, R/GA, and Young & Rubicam. He is an expert in designing high-impact marketing campaigns that integrate behavioral insights, analytics, and emerging media into brand experiences. Fred has played an instrumental role in delivering strategic solutions across a broad range of therapeutic categories for many tier-one health care companies including AbbVie, AstraZeneca, GSK, Johnson & Johnson/Janssen, Merck, Novartis, Novo-Nordisk and Pfizer.
A former attorney, Fred is a graduate of Columbia Business School's Executive Development Program. As a doctoral candidate in marketing at Pace University, he is conducting research into the factors effecting how consumers set and attain health- and wellness-related goals. His expertise includes market research, audience insights, strategic planning, digital, social and mobile marketing, data analytics, user experience design, and cross-functional team leadership.